(19)
(11) EP 2 211 843 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.10.2012 Bulletin 2012/42

(45) Mention of the grant of the patent:
01.08.2012 Bulletin 2012/31

(21) Application number: 08840088.2

(22) Date of filing: 17.10.2008
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
G02B 5/18(2006.01)
 A61J 3/00(2006.01)
(86) International application number:
PCT/US2008/011868
(87) International publication number:
WO 2009/051794 (23.04.2009 Gazette 2009/17)

(54)

PHARMACEUTICAL MOIRE PILL

PHARMAZEUTISCHE MOIRÉ-TABLETTE

PILULE PHARMACEUTIQUE MOIRÉE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 17.10.2007 US 980668 P
16.10.2008 US 105839

(43) Date of publication of application:
04.08.2010 Bulletin 2010/31

(73) Proprietor: GONIC International Ltd.
Singapore 309776 (SG)

(72) Inventors:
  • KLOCKE, Stefan
    76133 Karlsruhe (DE)
  • WALTER, Harald
    8810 Horgen Zürich (CH)
  • STUCK, Alexander
    CH-5430 Wettingen (CH)

(74) Representative: Beyer, Andreas 
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte Schweigerstrasse 2
81541 München
81541 München (DE)


(56) References cited: : 
WO-A-03/005839
 WO-A-2006/047695
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).